Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.

Eliaschewitz FG, de Paula MA, Pedrosa HC, Pires AC, Salles JEN, Tambascia MA, A Turatti LA.

Diabetes Metab Syndr. 2017 Aug 25. pii: S1871-4021(17)30281-3. doi: 10.1016/j.dsx.2017.08.011. [Epub ahead of print]

PMID:
28864058
2.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

PMID:
28854085
3.

Depression and alexithymia on weight perception in patients with metabolic syndrome and type 2 diabetes.

de Oliveira Regina MC, Tambascia MA.

Diabetol Metab Syndr. 2017 May 12;9:34. doi: 10.1186/s13098-017-0222-4. eCollection 2017.

4.

The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS).

Vilela BS, Vasques AC, Cassani RS, Forti AC, Pareja JC, Tambascia MA; BRAMS Investigators, Geloneze B.

PLoS One. 2016 Aug 4;11(8):e0158751. doi: 10.1371/journal.pone.0158751. eCollection 2016.

5.

Clinical use of the co-formulation of insulin degludec and insulin aspart.

Kumar A, Awata T, Bain SC, Ceriello A, Fulcher GR, Unnikrishnan AG, Arechavaleta R, Gonzalez-Gálvez G, Hirose T, Home PD, Kaku K, Litwak L, Madsbad S, Pinget M, Mehta R, Mithal A, Tambascia M, Tibaldi J, Christiansen JS.

Int J Clin Pract. 2016 Aug;70(8):657-67. doi: 10.1111/ijcp.12821. Epub 2016 Jul 7. Review.

PMID:
27384031
6.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

7.

Degludec: the new ultra-long insulin analogue.

Tambascia MA, Eliaschewitz FG.

Diabetol Metab Syndr. 2015 Jun 26;7:57. doi: 10.1186/s13098-015-0037-0. eCollection 2015.

8.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

9.

Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Moura Neto A, Parisi MC, Alegre SM, Pavin EJ, Tambascia MA, Zantut-Wittmann DE.

Endocrine. 2016 Jan;51(1):63-71. doi: 10.1007/s12020-015-0651-5. Epub 2015 Jun 7.

PMID:
26049370
10.

Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population--Brazilian Metabolic Syndrome Study (BRAMS).

Vasques AC, Cassani RS, Forti AC, Vilela BS, Pareja JC, Tambascia MA, Geloneze B; BRAMS Investigators.

PLoS One. 2015 May 7;10(5):e0125365. doi: 10.1371/journal.pone.0125365. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134747.

11.

Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance.

Comucci EB, Vasques AC, Geloneze B, Calixto AR, Pareja JC, Tambascia MA.

Arq Bras Endocrinol Metabol. 2014 Oct;58(7):709-14.

12.

Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.

Tambascia MA, Malerbi DA, Eliaschewitz FG.

Einstein (Sao Paulo). 2014 Apr;12(2):251-3. English, Portuguese.

13.

Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.

Bertoluci MC, Pimazoni-Netto A, Pires AC, Pesaro AE, Schaan BD, Caramelli B, Polanczyk CA, Júnior CV, Gualandro DM, Malerbi DA, Moriguchi E, Borelli FA, Salles JE, Júnior JM, Rohde LE, Canani LH, Cesar LA, Tambascia M, Zanella MT, Gus M, Scheffel RS, Dos Santos RD.

Diabetol Metab Syndr. 2014 May 20;6:58. doi: 10.1186/1758-5996-6-58. eCollection 2014. Review.

14.

Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.

Geloneze B, de Oliveira Mda S, Vasques AC, Novaes FS, Pareja JC, Tambascia MA.

Metabolism. 2014 Jul;63(7):922-9. doi: 10.1016/j.metabol.2014.04.004. Epub 2014 Apr 12.

PMID:
24854384
15.

High Prevalence of Infertility among Women with Graves' Disease and Hashimoto's Thyroiditis.

Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado Hda C, Fernandes A.

Int J Endocrinol. 2014;2014:982705. doi: 10.1155/2014/982705. Epub 2014 Feb 11.

16.

[I Brazilian Guidelines for cardiovascular prevention].

Simão AF, Precoma DB, Andrade JP, Correa FH, Saraiva JF, Oliveira GM, Murro AL, Campos A, Alessi A, Avezum A Jr, Achutti AC, Miguel AC, Sousa AC, Lotemberg AM, Lins AP, Falud AA, Brandão AA, Sanjuliani AF, Sbissa AS, Alencar FA, Herdy AH, Polanczyk CA, Lantieri CJ, Machado CA, Scherr C, Stoll C, Amodeo C, Araújo CG, Saraiva D, Moriguchi EH, Mesquita ET, Fonseca FA, Campos GP, Soares GP, Feitosa GS, Xavier HT, Castro I, Giuliano IC, Rivera IV, Guimaraes IC, Issa JS, Souza JR, Faria NJ, Cunha LB, Pellanda LC, Bortolotto LA, Bertolami MC, Miname MH, Gomes MA, Tambascia M, Malachias MV, Silva MA, Izar MC, Magalhães ME, Bacellar MS, Milani M, Wajngarten M, Ghorayeb N, Coelho OR, Villela PB, Jardim PC, Santos Filho RD, Stein R, Cassani RS, D'Avila RI, Ferreira RM, Barbosa RB, Povoa RM, Kaiser SE, Ismael SC, Carvalho T, Giraldez VZ, Coutinho W, Souza WK; Sociedade Brasileira de Cardiologia.

Arq Bras Cardiol. 2013 Dec;101(6 Suppl 2):1-63. doi: 10.5935/abc.2013S012. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2014 Apr;102(4):415. Cesena, F H Y [removed].

17.

Evidence-based clinical use of insulin premixtures.

Tambascia MA, Nery M, Gross JL, Ermetice MN, de Oliveira CP.

Diabetol Metab Syndr. 2013 Sep 6;5(1):50. doi: 10.1186/1758-5996-5-50.

18.

Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases.

Lima PC, Moura Neto A, Tambascia MA, Zantut Wittmann DE.

ISRN Endocrinol. 2013 May 25;2013:673146. doi: 10.1155/2013/673146. Print 2013.

19.

The influence of body mass index and low-grade systemic inflammation on thyroid hormone abnormalities in patients with type 2 diabetes.

Moura Neto A, Parisi MC, Tambascia MA, Alegre SM, Pavin EJ, Zantut-Wittmann DE.

Endocr J. 2013;60(7):877-84. Epub 2013 Apr 5.

20.

Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.

Moura Neto A, Parisi MC, Tambascia MA, Pavin EJ, Alegre SM, Zantut-Wittmann DE.

Endocrine. 2014 Feb;45(1):84-91. doi: 10.1007/s12020-013-9938-6. Epub 2013 Apr 2.

PMID:
23546612

Supplemental Content

Loading ...
Support Center